Mochizuki M, Maruo T
Acta Physiol Hung. 1985;65(3):267-74.
In order to elucidate the effects of dehydroepiandrosterone sulfate (DHAS) on softening and dilatation of the uterine cervix, changes of oestriol, 17 beta-oestradiol and progesterone levels in serum and cervix, Bishop score and collagenase activity in the cervical tissue were assessed in pregnant women before and after treatment with DHAS. 17 beta-oestradiol level in the serum and cervical tissue markedly increased after the administration of DHAS, while oestriol level remained unchanged. Serum progesterone level did not change in the majority of cases, while it decreased within several hours in patients in whom delivery was accomplished within 24 hours after the administration of DHAS. Among the factors connected with the Bishop score, effacement and consistency of the cervix were remarkably improved by DHAS administration. Total collagenase activity in the cervical tissue of patients treated with DHAS was elevated by an average of 152%. These results suggest that DHAS is potent in ripening the uterine cervix through an activation of collagenase activity induced by the enhanced conversion to 17 beta-oestradiol. Thus, DHAS administration in the late stage of pregnancy is valuable in prepartal treatment for induction of labour.
为了阐明硫酸脱氢表雄酮(DHAS)对子宫颈软化和扩张的影响,对接受DHAS治疗前后的孕妇血清和子宫颈中雌三醇、17β-雌二醇和孕酮水平的变化、Bishop评分以及子宫颈组织中的胶原酶活性进行了评估。给予DHAS后,血清和子宫颈组织中的17β-雌二醇水平显著升高,而雌三醇水平保持不变。大多数情况下血清孕酮水平未发生变化,而在给予DHAS后24小时内完成分娩的患者中,其在数小时内下降。在与Bishop评分相关的因素中,给予DHAS后子宫颈的消退和质地明显改善。接受DHAS治疗的患者子宫颈组织中的总胶原酶活性平均升高了152%。这些结果表明,DHAS通过增强向17β-雌二醇的转化诱导胶原酶活性,从而有效地使子宫颈成熟。因此,在妊娠晚期给予DHAS在产前引产治疗中具有重要价值。